CALISTA THERAPEUTICS, INC.

Basic Information

32 RIVERSIDE DR
LINCOLN, RI, 02865-1511

Company Profile

n/a

Additional Details

Field Value
DUNS: 078513201
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 1


  1. Calcaftor, a CFTR stabilizer for Cystic Fibrosis treatment

    Amount: $224,550.00

    DESCRIPTION (provided by applicant): Calista Therapeutics has invented Calcaftor, a first-in-class peptide drug that can treat all Cystic Fibrosis (CF) patients. Calcaftor is validated in the gold sta ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. An Automated Platform for High-throughput Network Electrophysiology

    Amount: $224,993.00

    DESCRIPTION (provided by applicant): Calista Therapeutics has discovered a first-in-class, proprietary PDZ1-2 lead drug, AT010, that is being optimized and developed as an inhaled daily therapy for cy ...

    SBIR Phase I 2013 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government